GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $103.00

GE HealthCare Technologies (NASDAQ:GEHC) had its price target increased by Wells Fargo & Company from $96.00 to $103.00 in a research report sent to investors on Friday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock.

Several other equities research analysts have also issued reports on the stock. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $97.85.

GE HealthCare Technologies Trading Down 1.4 %

Shares of NASDAQ:GEHC opened at $92.21 on Friday. The firm has a fifty day moving average of $84.03 and a two-hundred day moving average of $85.51. The firm has a market capitalization of $42.13 billion, a P/E ratio of 25.33, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. GE HealthCare Technologies has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. On average, equities analysts expect that GE HealthCare Technologies will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th were given a dividend of $0.035 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date was Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.15%. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in GEHC. Cherry Creek Investment Advisors Inc. increased its stake in GE HealthCare Technologies by 0.3% in the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock valued at $2,920,000 after acquiring an additional 114 shares during the period. Independence Bank of Kentucky increased its stake in GE HealthCare Technologies by 6.0% in the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock valued at $158,000 after acquiring an additional 114 shares during the period. Haverford Trust Co increased its stake in GE HealthCare Technologies by 2.4% in the fourth quarter. Haverford Trust Co now owns 4,896 shares of the company’s stock valued at $383,000 after acquiring an additional 115 shares during the period. Tandem Capital Management Corp ADV increased its stake in GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock valued at $2,205,000 after acquiring an additional 118 shares during the period. Finally, Arcus Capital Partners LLC grew its stake in GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company’s stock worth $322,000 after buying an additional 119 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.